Predicting cancer evolution with deep learning algorithms
New proof-of-concept approach offers faster, more accurate inferences about tumour populations.
Excerpt from the Press Release:
The prevalence of mutations in a tumour can provide clues about how the cancer has grown or evolved and how best to treat it.
But making predictions about the evolution of mutated tumours using a single DNA sequenced biopsy requires complex estimates, and current methods are either slow, or don’t always consider why certain subpopulations of cells proliferate more than others.
This led a pair of researchers at the Ontario Institute for Cancer Research (OICR) to develop a new method for understanding and predicting cancer evolution that harnesses modern deep learning algorithms and incorporates evolutionary modeling.
TumE is a deep learning approach that analyzes the frequency of mutations in a biopsy — known as the variant allele frequency — to identify which subpopulation of mutated cells that are most “fit” and thus most likely to make a tumour stronger.
Click the button below to read the entire Press Release:
Discover What Sets TrialStat Apart From Ordinary EDC Platforms
Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?